APC anti-mouse TER-119/Erythroid Cells Antibody

Product Details

Verified Reactivity

Mouse

Antibody Type

Monoclonal

Host Species

Rat

Immunogen

Day-14 fetal liver cells from a C57BL/6 mouse

Formulation

Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.

Preparation

The antibody was purified by affinity chromatography, and conjugated with APC under optimal conditions.

Concentration

0.2 mg/ml

Storage & Handling

The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.

Application

FC - Quality tested

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤1.0 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser

Red Laser (633 nm)

Application Notes

The TER-119 antibody is useful for distinguishing erythrocytes and cells in the erythroid lineage. Additional reported applications (for the relevant formats) include: immunoprecipitation¹, Western blotting¹, complement-mediated cytotoxicity³, and immunohistochemical staining of acetone-fixed frozen sections and formalin-fixed paraffin-embedded sections. Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. No. 116253-116258).

Application References

(PubMed link indicates BioLegend citation)

1. Kina T, et al. 2000. Br. J. Haematol. 109:280. (IP, WB)
2. Vannucchi AM, et al. 2000. Blood 95:2559.
3. Maraskovsky E, et al. 1996. J. Exp. Med. 184:1953. (CMCD)
4. Grisendi S, et al. 2005. Nature 437:147. (FC)
5. Bourdeau A, et al. 2007. Blood 109:4220.
6. Chappaz S, et al. 2007. Blood 110:3862. (FC)
7. Heuser M, et al. 2007. Blood 110:1639. (FC)
8. Gough SM, et al. 2014. Cancer Discov. 4:564. PubMed

Product Citations

1. DeSouza-Vieira T, et al. 2020. Cell Rep. 33:108317. PubMed
2. Koury D, et al. 2017. Int J Parasitol. 10.1016/j.ijpara.2017.05.009. PubMed
3. Wang L, et al. 2018. Bone Res. 6:22. PubMed
4. Yang D, et al. 2022. Cell. 185:1905. PubMed
5. Chappaz S, et al. 2021. Cell Reports. 36(3):109430. PubMed
6. Viny AD, et al. 2019. Cell Stem Cell. 25:682. PubMed
7. Ray S, et al. 2020. J Biol Chem. 295:7113. PubMed
8. Mourao L, et al. 2019. Sci Rep. 0.991666667. PubMed
9. Tanimura N et al. 2018. Developmental cell. 46(5):581-594 . PubMed
10. Symeonidou V, et al. 2021. Cell Rep. 37:109900. PubMed
11. Yu VWC et al. 2016. Cell. 167(5):1310-1322 . PubMed
12. Yanagida K, et al. 2020. Dev Cell. 779:52. PubMed
13. Larouche JA, et al. 2021. eLife. 0.416666666666667. PubMed
14. Engelbrecht E, et al. 2020. eLife. 9:e52690.. PubMed
15. Lutzmann M, et al. 2019. Cell Rep. 28:2851. PubMed
16. Li C, et al. 2021. Mol Ther. 29:822. PubMed
17. Liu P, et al. 2020. Genome Res. 30:1655. PubMed
18. Yeo S, et al. 2016. Cancer Res . 76: 3397 - 3410. PubMed
19. Liu J, et al. 2012. PLoS One. 7:e44044. PubMed
20. Bilodeau M, et al. 2009. PLoS One. 4:e7500. PubMed
21. Dey A et al. 2019. The EMBO journal. 38(7) pii: e100293. PubMed
22. Nishina T, et al. 2021. Nat Commun. 12:2281. PubMed
23. Lafkas D, et al. 2013. J Cell Biol. 203:47. PubMed
24. Kunimoto H, et al. 2018. Cancer Cell. 33:44. PubMed
25. Parada-Kusz M, et al. 2018. Dis Model Mech. 11:. PubMed
26. Stivala S, et al. 2019. J Clin Invest. 130:1596. PubMed
27. Samarchith P Kurup et al. 2019. Cell host & microbe. 25(4):565-577 . PubMed
28. Riffelmacher T et al. 2017. Immunity. 47(3):466-480 . PubMed
29. Hillel–Karniel C, et al. 2020. Cell Reports. 30(3):807-819.e4.. PubMed
30. Liu S, et al. 2021. Mol Ther. 29:1918. PubMed
31. Shcherbina A, et al. 2020. Cell Rep. 32:107964. PubMed
32. Guihard S, et al. 2010. Blood. 115:3686. PubMed
33. Yu VWC, et al. 2017. Cell. 168:944. PubMed
34. Chen X et al. 2017. Cell stem cell. 21(6):747-760 . PubMed
35. Pal B, et al. 2017. Nat Commun.. 10.1038/s41467-017-01560-x. PubMed
36. Haase C, et al. 2022. Nat Methods. 19:1622. PubMed
37. Negretti NM, et al. 2021. Development. 148:. PubMed
38. Nayak RR, et al. 2021. Cell Host Microbe. 29(3):362-377.e11. PubMed
39. Crowe JL, et al. 2020. Proc Natl Acad Sci U S A. 22953:117. PubMed
40. Sá da Bandeira D, et al. 2022. Cell Rep. 40:111114. PubMed
41. Saleiro D, et al. 2022. Nat Commun. 13:1750. PubMed
42. Pezoldt J, et al. 2022. Nat Commun. 13:7227. PubMed
43. Perez E, et al. 2020. J Immunol. 205:2489. PubMed
44. Nosho S, et al. 2020. Int J Mol Sci. 21:00. PubMed
45. Kruta M, et al. 2021. Cell Stem Cell. :. PubMed
46. Dagher T, et al. 2021. J Exp Med. 218:. PubMed
47. Liu Z, et al. 2020. Cell. 178(6):1509-1525.e19.. PubMed
48. Shin JJ, et al. 2020. Cell Rep. 32:108093. PubMed
49. Goldstein JM et al. 2019. Cell reports. 27(4):1254-1264 . PubMed
50. Li G, et al. 2020. J Clin Invest. 130:1233. PubMed
51. Long JT, et al. 2022. Elife. 11:. PubMed
52. Chen R, et al. 2021. Cell Reports. 34(7):108751. PubMed
53. Nahrendorf W, et al. 2021. eLife. 10:00. PubMed
54. Song J, et al. 2014. Exp Cell Res. 327:123. PubMed
55. Wang H, et al. 2019. J Clin Invest. 129:598. PubMed
56. Hou Y, et al. 2021. Sci Transl Med. 13:. PubMed
57. Maroni G, et al. 2019. Int J Mol Sci. 20. PubMed
58. Carmody C et al. 2019. Endocrinology. 160(5):1205-1222 . PubMed
59. Fu NY, et al. 2018. Dev Cell. 47:629. PubMed
60. Siddique SM, et al. 2019. Sci Rep. 9:13977. PubMed
61. Yeo SK, et al. 2020. eLife. 9:e58810.. PubMed
62. Omatsu Y, et al. 2022. Nat Commun. 13:2654. PubMed
63. Liu W, et al. 2022. J Clin Invest. 132: . PubMed
64. Chen C, et al. 2020. Cell Rep. 2136:30. PubMed
65. Ma L, et al. 2022. Sci Adv. 8:eabm3470. PubMed
66. Cambridge E, et al. 2017. Exp Hematol. 45:64-68.e5. PubMed
67. Markworth JF, et al. 2020. JCI Insight. 5:00. PubMed
68. Wang H, et al. 2020. JCI Insight. 5:00. PubMed
69. Maeda K, et al. 2021. Pathogens. 10:. PubMed
70. Magee JA, et al. 2021. Stem Cell Reports. 16:20. PubMed
71. Rai S, et al. 2022. Nat Commun. 13:5346. PubMed
72. Khoriaty R, et al. 2014. Mol Cell Biol. 34:3721. PubMed
73. Woods B, et al. 2019. Clin Cancer Res. 25:5901. PubMed
74. Hidalgo San Jose L, et al. 2020. Cell Rep. 30:69. PubMed
75. Pal B, et al. 2021. Breast Cancer Res. 23:69. PubMed
76. Maller O, et al. 2020. Nat Mater. 20:548. PubMed
77. Yin Y, et al. 2016. J Biol Chem. 291: 6923 - 6935. PubMed
78. Rowe R, et al. 2016. J Exp Med. 213: 1497 - 1512. PubMed
79. Werner MT, et al. 2020. J Biol Chem. 295:1898. PubMed
80. Koyama M et al. 2019. Immunity. 51(5):885-898 . PubMed
81. Awida Z, et al. 2021. Int J Mol Sci. 23:. PubMed
82. Lam J, et al. 2018. Nat Commun. 9:2418. PubMed
83. Schmidts A, et al. 2020. J Immunother Cancer. 8:. PubMed
84. Murray CW, et al. 2022. Nat Commun. 13:1090. PubMed

RRID

AB_313712 (BioLegend Cat. No. 116211)
AB_313713 (BioLegend Cat. No. 116212)

Antigen Details

Structure

Associated with glycophorin A, 52 kD

Distribution

Early proerythroblast to mature erythrocyte, but not BFU-E and CFU-E

Cell Type

Erythrocytes

Biology Area

Immunology

Antigen References

1. Kina T, et al. 2000. Br. J. Haematol. 109:280.
2. Ikuta K, et al. 1990. Cell 62:863.
3. Osawa M, et al. 1996. Weir's Handbook of Experimental Immunology. Vol. 2 pp. 66.1-66.5.

Gene ID

104231 View all products for this Gene ID

UniProt

View information about TER-119 on UniProt.org

Documentation

• Technical Data Sheet (pdf)
• Certificate of Analysis
• Safety Data Sheet

Reviews

Related Protocols

• Cell Surface Flow Cytometry Staining Protocol

Related Pages & Pathways

Related FAQs

Other Formats

Certificate of Analysis